The discovery, reported in the article “Arpc 1b, a centrosomal protein, is both an activator and substrate of Aurora A,” furthers the science world’s understanding of what happens during the fundamental process of mitosis, when cells divide. The article was published in the current issue of The Journal of Cell Biology.
“This represents a crucial moment when the division of genetic material is still equally distributed. An even exchange is critical for stable genetic changes,” said Rakesh Kumar, Ph.D., chair of the GW Department of Biochemistry and Molecular Biology. In mitosis, cells begin to divide and genetic material coalesces around separate poles to form new cells. If all goes well that material is evenly distributed and two genetically identical “daughter cells” are formed. If something goes awry, however, it can result in the cascading production of aberrant cells with unequal and less ordered DNA and possibly cancer.
Lead authors Poonam R. Molli, Ph.D., ex-postdoctoral fellow, and Da-Qiang Li, M.D., assistant research professor, from GW’s Department of Biochemistry and Molecular Biology, have identified a protein, Arpc 1b, that serves as both an activator as well as a substrate for Aurora A, an enzyme which plays a central role in cellular reproduction in normal cells but is overexpressed in several cancers. This represents perhaps the earliest step in mitosis and serves as the missing link regarding the role this protein plays in starting the cell cycle and what keeps the process in balance. The authors discovered that Arpc1b also exists as a stand alone protein and believe that it might also play an independent role outside its established contribution to actin machinery.
More than just an observation of how cells divide, this discovery also offers a potential target for pharmaceutical therapy. Both Aurora A and Arpc1b are over-expressed in breast cancers. Pharmaceutical inhibitors targeting Aurora A are currently available and thus, could be combined with other future targeting strategies. The researchers discovered that an over-expression of Arpc1b promotes tumorigenic properties of breast cancer cells. Scientists believe that if they can someday find a means of suppressing the activity of Arpc 1b in cancer cell, the balance could be restored to this dynamic yet tightly regulated biological event.
“This discovery is the result of persistence and the commitment to scientific breakthrough,” said Dr. Kumar. “Asking a question and staying involved until you find the answer to close the loop is critical in scientific discovery.” In this case the earliest piece of data used here was obtained in 2001.
To learn more about this research, view The Journal of Cell Biology article: http://jcb.rupress.org/content/early/2010/06/30/jcb.200908050.full
Anne Banner | Newswise Science News
Staying in Shape
16.08.2018 | Max-Planck-Institut für molekulare Zellbiologie und Genetik
Chips, light and coding moves the front line in beating bacteria
16.08.2018 | Okinawa Institute of Science and Technology (OIST) Graduate University
Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...
Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.
When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...
Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.
Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....
Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.
Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...
Scientists have discovered that the electrical resistance of a copper-oxide compound depends on the magnetic field in a very unusual way -- a finding that could help direct the search for materials that can perfectly conduct electricity at room temperatur
What happens when really powerful magnets--capable of producing magnetic fields nearly two million times stronger than Earth's--are applied to materials that...
08.08.2018 | Event News
27.07.2018 | Event News
25.07.2018 | Event News
16.08.2018 | Life Sciences
16.08.2018 | Earth Sciences
16.08.2018 | Life Sciences